Germany

The BMWs and Mercs will be banned from the autobahns. People will only have electricity when there is enough of a breeze to keep the windmills turning. And the factories will be on a three-day week, while the airports will be converted into organic farms. Most businesses, and of course conservatives of any sort, will be nervous at the increasingly likely prospect of the Greens taking charge in Berlin later this year. But they shouldn’t be. In fact, they would be a huge improvement on Angela Merkel’s chaotic twilight years. As she heads towards retirements, Merkel’s legacy is looking very tarnished. The CDU is slumping in the polls. It has

On Sunday, Angela Merkel’s Christian Democratic Union of Germany (CDU) suffered a historic election defeat in their former heartlands of Baden-Württemberg and Rhineland-Palatinate. ‘The state elections struck deep at the heart of the union of the CDU and CSU,’ said Markus Söder, leader of the CDU’s Bavarian sister party, the Christian Social Union. To an increasingly frustrated public, the ruling parties in the capital look tired and devoid of ideas. There is no incentive for Merkel and her cabinet to turn things around. After 16 years in government and on the brink of retirement, she has become a lame-duck chancellor. Some German journalists have even begun to call the whole

Young, polished and confident, Germany’s health minister became the country’s most popular politician in 2020. A darling of the conservative right, Jens Spahn, was even tipped as a candidate to succeed Angela Merkel as chancellor. At the peak of his popularity last November, surveys indicated approval from nearly two-thirds of all Germans. He seemed to reflect the success story that was Germany’s handling of the pandemic, the personification of friendly German efficiency. Fast forward to last week, and you find a defensive Spahn facing a hostile one-hour long grilling in parliament. His arms crossed and his jaw set, the 40-year-old was visibly tense as he braced himself for questions from

Germany’s fridges are filled with Oxford jabs. But there’s a problem: 80 per cent of the 735,000 doses delivered to Germany so far have not been used. The vaccine is being described in the German press as a ‘shelf warmer’. There are even reports of people missing appointments at vaccination centres if they have been notified that they will receive the AstraZeneca product. While this is alarming, a lukewarm reaction to the vaccine might not come as a surprise. The vaccine’s reputation has been repeatedly undermined by reports about its efficacy. A decision in Germany not to use the vaccine for over-65-year-olds, despite the European Medicines Agency having approved it to be given to

Germans are increasingly losing faith in the European Union due to its bungled handling of the vaccine roll-out. Germany and the other member states have assigned Brussels to organise and oversee the procurement and distribution of Covid jabs. But, so far, the roll-out has been a logistic mess. According to a poll by Civey, commissioned by the German newspaper Der Spiegel, more than 60 per cent of German citizens said their view of Brussels had worsened in light of the disastrous vaccination management. Almost 70 per cent laid the blame at the feet of fellow German Ursula von der Leyen, the President of the European Commission, who admitted last week

Two months ago, a Russian pipe-laying ship called the Akademik Cherskiy left the Baltic island of Rügen to finish the last few miles of the most controversial gas pipeline in the world. Germany hopes that Nord Stream 2 will improve its access to Russia’s vast reserves of natural gas. In America, however, the project is seen as a way for Moscow to exert influence over Europe. Its completion marks the biggest diplomatic crisis in transatlantic relations since the Iraq War and now, as then, we see Germany pitched against the US. But this time, Germany is far more determined. Since its inception, the pipeline —which runs directly from Russia to

After the EU’s vaccine distribution disaster, German lawmakers are now taking a closer look at Russia’s Sputnik V jab. If approved by EU regulators, Sputnik V could be the fourth vaccine available in the bloc after the BioNTech-Pfizer, Moderna and AstraZeneca vaccines. It’s easy to see why Germany could be tempted by the Sputnik V vaccine. The rollout of the BioNTech-Pfizer and Moderna jabs has been hampered by delivery delays and political blunders. And European regulators have remained wary of AstraZeneca’s vaccine – a scepticism that was solidified by a recent trial showing that the shot may not significantly reduce the risk of mild or moderate disease caused by the

Germany’s vaccine committee has advised the Oxford-AstraZeneca vaccine only be given to under-65s. The announcement marks a major twist in a week of muddled vaccine reports. On Tuesday, the German newspaper Handelsblatt suggested that German officials believed the Oxford vaccine was only 8 per cent effective for the over-65 groups (no evidence has been produced to support the 8 per cent claim). It has been heavily and extensively rebuffed by both AstraZeneca and the German government. Yet the German reporter who broke the story doubled down on the claims, raising the stakes as to whether he was making precarious reporting worse, or whether the European Medicines Agency may indeed conclude that the vaccine’s efficacy is too low. As

Yesterday’s extraordinary row over the Oxford-AstraZeneca vaccine has just become even stranger. The German government spent much of Tuesday rubbishing reports they had found the jab to be only 8 per cent effective among the over 65s. A claim that was published by the Düsseldorf-based financial paper Handelsblatt following a tip-off from anonymous sources within the German government. Instead, according to the country’s health ministry, there had been a very embarrassing misunderstanding:  At first glance it seems that the reports have mixed up two things: about 8 per cent of those tested in the AstraZeneca efficacy study were between 56 and 69… But one cannot deduce an efficacy of only 8 per cent with older

Angela Merkel is known for her competency, yet even Mutti’s defenders would struggle to use that word to describe Germany’s rollout of the Covid-19 vaccine. German firm BioNTech won the race to develop a vaccine, but this has not prevented crippling supply shortages, which has forced states including North Rhine-Westphalia, in the west of the country, to suspend jabs.  German health minister Jens Spahn has come under fire and his insistence that ‘the vaccine is a scarce product worldwide’ rings hollow when Germans look at the speed of the vaccine rollout in Britain. Now, to make matters worse, German’s health ministry has found itself caught in a fresh row: over the effectiveness of the AstraZeneca Covid-19 vaccine. German newspaper Handelsblatt reported

Germany’s new lockdown has hit its people like a lightning bolt. On Tuesday, Angela Merkel and the 16 federal state leaders decided that those in coronavirus hotspots should not be allowed to travel beyond a nine-mile radius (15 kilometres) if they don’t have a valid reason.     Valid reasons include a visit to a doctor’s office, shopping for necessities and commuting to work. Yet many Germans feel that the new regulations are arbitrary and affect rural areas much more than cities. The nine-mile radius as a metric is added to the edge of the town, meaning that those living in a large city still have a lot of space where